Latest On-Demand Webinars

In this webinar, our guest speakers will be discussing how to harness the full power of this disease-agnostic RNA platform, the key considerations needed for consistent, high-quality mRNA synthesis and how you can intensify manufacturing for rapid therapeutic production.

Human induced pluripotent stem cells (iPSC) can renew almost indefinitely and differentiate to any adult cell in the body thus making them ideal materials for developing new cell-based therapies. The efficacy and manufacturability of these therapies critically rely on reagents such as media and surface substrates used during iPSC expansion and differentiation outcomes.

Speaking at Cell & Gene Therapy 2023, Dr. Gabriella Perell and Dr. Xi Lu from Bio-Techne, presented their talk on Biotechne’s portfolio of cGMP and animal-free reagents including iPSC expansion media, vitronectin culture substrates, small molecules, and growth factors. Dr, Perell and Dr. Lu will demonstrate the application of these reagents towards establishing an iPSC to iNK workflow.

In this webinar, our expert speakers will focus on various gene editing systems and how you can utilize analytical instrumentation to characterize the various components.

Outsourcing chemical supply to a trusted management partner offers significant benefits over self-managed alternatives. Benefits include greater flexibility, decreased risk, and higher raw material quality while the cost of ownership is reduced.

The polymerase chain reaction (qPCR) is firmly established as the method of choice for the detection of microbial agents in the areas of clinical, veterinary and agricultural diagnostics and food safety. The current pandemic has highlighted the critical importance of local, fast and specific testing for SARS-CoV-2. It should also act as a wake-up call for the threat posed by infectious diseases spreading because of climate change, increasing antibiotic resistance and the hazard of zoonotic transfer caused by human encroachment of animal habitats. We are working on new tests, protocol and reagents to achieve faster molecular diagnostic testing both for both laboratory based and POC applications. Our target of delivering a diagnostic test result within five minutes of sampling has the potential to lead to a paradigm shift in our approach to detecting and classifying microbial pathogens in preparation for the inevitable next pandemic

In this webinar, Professor Marius Wernig from Stanford University and Dr. Mark Kotter, CEO and founder of bit.bio offer an expert discussion on the pioneering research of cell reprogramming.

In this webinar, we explore the chemical reactions and strategies of oligonucleotide synthesis in mechanistic detail, with simple overviews for non-chemists.

Our expert speaker, Professor Tom Brown, will review the history of oligonucleotide synthesis, examine how they are made currently and highlight emerging synthesis methods, including enzymatic approaches. He will also discuss the various applications of synthetic oligonucleotides, from diagnostics to therapeutics and more.

In this webinar, we explore the chemical reactions and strategies of oligonucleotide synthesis in mechanistic detail, with simple overviews for non-chemists.

Our expert speaker, Professor Tom Brown, will review the history of oligonucleotide synthesis, examine how they are made currently and highlight emerging synthesis methods, including enzymatic approaches. He will also discuss the various applications of synthetic oligonucleotides, from diagnostics to therapeutics and more.

In this webinar, we explore the chemical reactions and strategies of oligonucleotide synthesis in mechanistic detail, with simple overviews for non-chemists.

Our expert speaker, Professor Tom Brown, will review the history of oligonucleotide synthesis, examine how they are made currently and highlight emerging synthesis methods, including enzymatic approaches. He will also discuss the various applications of synthetic oligonucleotides, from diagnostics to therapeutics and more.

RNA dependent RNA polymerase (RdRp), is essential in the RNA replication within the life cycle of the severely acute respiratory coronavirus-2 (SARS-CoV-2), causing the deadly respiratory induced sickness COVID-19.